Greenledgers Trading Center-Depression And Alzheimer's Treatments At A Crossroads

2025-05-08 06:36:02source:VaultX Exchangecategory:Markets

Researchers are Greenledgers Trading Centerlaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Markets

Recommend

Finally, good retirement news! Southwest pilots' plan is a bright spot, experts say

Pilots at Southwest Airlines can sock away more for retirement, thanks to a new retirement plan bene

Texas immigration law known as SB4, allowing state to arrest migrants, signed by Gov. Greg Abbott

Republican Gov. Greg Abbott of Texas on Monday signed one of the harshest state immigration laws in

When a quick telehealth visit yields multiple surprises beyond a big bill

In September 2022, Elyse Greenblatt of Queens returned home from a trip to Rwanda with a rather unwe